日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Development of the Observer Scales of the Patient and Observer Scar Assessment Scale: An International Delphi Study

患者和观察者疤痕评估量表观察者评分标准的制定：一项国际德尔菲研究

期刊:Plastic and Reconstructive Surgery-Global Open
影响因子:1.8
doi:10.1097/GOX.0000000000006416
Carrière, Michelle E; Mokkink, Lidwine B; Pleat, Jonathon; Tyack, Zephanie; Pijpe, Anouk; de Vet, Henrica C W; van Zuijlen, Paul P M
表观遗传
发表日期：2025
文献求助 收藏

Development of the Patient Scale of the Patient and Observer Scar Assessment Scale (POSAS) 3.0: a qualitative study

患者和观察者疤痕评估量表（POSAS）3.0患者量表的开发：一项定性研究

期刊:Quality of Life Research
影响因子:2.7
doi:10.1007/s11136-022-03244-6
Carrière, M E; Mokkink, L B; Tyack, Z; Westerman, M J; Pijpe, A; Pleat, J; van de Kar, A L; Brown, J; de Vet, H C W; van Zuijlen, P P M
发表日期：2023
文献求助 收藏

Stability is maintained in adults with Gaucher disease type 1 switched from velaglucerase alfa to eliglustat or imiglucerase: A sub-analysis of the eliglustat ENCORE trial

在戈谢病 1 型成人患者中，从维拉葡糖苷酶α换用依利葡糖苷酶或伊米葡糖苷酶后，病情保持稳定：依利葡糖苷酶 ENCORE 试验的亚组分析

期刊:Molecular Genetics and Metabolism Reports
影响因子:1.9
doi:10.1016/j.ymgmr.2016.08.009
Pleat, Rebecca; Cox, Timothy M; Burrow, T Andrew; Giraldo, Pilar; Goker-Alpan, Ozlem; Rosenbloom, Barry E; Croal, Laura R; Underhill, Lisa H; Gaemers, Sebastiaan J M; Peterschmitt, M Judith
发表日期：2016
文献求助 收藏

Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships

早期使用拉罗尼酶治疗可改善轻型MPS I患者的临床结果：一项对九个同胞家庭的回顾性病例系列分析

期刊:Orphanet Journal of Rare Diseases
影响因子:3.5
doi:10.1186/s13023-015-0344-4
Al-Sannaa, Nouriya A; Bay, Luisa; Barbouth, Deborah S; Benhayoun, Youssef; Goizet, Cyril; Guelbert, Norberto; Jones, Simon A; Kyosen, Sandra Obikawa; Martins, Ana Maria; Phornphutkul, Chanika; Reig, Celia; Pleat, Rebecca; Fallet, Shari; Ivanovska Holder, Iva
发表日期：2015
文献求助 收藏